Home | Services | Products | Support | Useful Documents | Experience | Staff | Opportunities  
 
   
News
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of treatment of hypercholesterolemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinsonís disease
Ross McLeod joins World Health Organization Technical and Scientific Advisory Group on the Development of Target Product Profiles (TPPs) for Snake Antivenom Products
Annual Costs of Feral Deer in Australia
 
 

Latest News  
   
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health study of treatment of hypercholesterolemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
 



The aim of the Health Technology Assessment (HTA) is to evaluate the efficacy, safety, cost-effectiveness, and budgetary impact of ezetimibe-containing medicines compared to statins or fenofibrate in patients with hypercholesterolaemia or mixed/combined hyperlipidaemia. https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/ezetimib.html

Previous News

Next News